0001415889-20-001398.txt : 20200601 0001415889-20-001398.hdr.sgml : 20200601 20200601171007 ACCESSION NUMBER: 0001415889-20-001398 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200601 FILED AS OF DATE: 20200601 DATE AS OF CHANGE: 20200601 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BORKOWSKI EDWARD CENTRAL INDEX KEY: 0001197542 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37853 FILM NUMBER: 20934272 MAIL ADDRESS: STREET 1: 1500 CORPORATE DRIVE STREET 2: SUITE 400 CITY: CANONSBURG STATE: PA ZIP: 15317 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AzurRx BioPharma, Inc. CENTRAL INDEX KEY: 0001604191 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 760 PARKSIDE AVENUE STREET 2: SUITE 304 CITY: BROOKLYN STATE: NY ZIP: 11226 BUSINESS PHONE: 646-699-7855 MAIL ADDRESS: STREET 1: 760 PARKSIDE AVENUE STREET 2: SUITE 304 CITY: BROOKLYN STATE: NY ZIP: 11226 FORMER COMPANY: FORMER CONFORMED NAME: BioPharma d'Azur, Inc. DATE OF NAME CHANGE: 20140331 4 1 form4-06012020_020653.xml X0306 4 2020-06-01 0001604191 AzurRx BioPharma, Inc. AZRX 0001197542 BORKOWSKI EDWARD C/O AZURRX BIOPHARMA, INC. 760 PARKSIDE AVE SUITE 304 BROOKLYN NY 11226 true false false false 9.0% Senior Convertible Promissory Note 0.97 2020-06-01 4 D 0 100000 100000 D 2019-12-20 2020-09-20 Common Stock 103093 0 D 9.0% Senior Convertible Promissory Note 1.07 2020-06-01 4 A 0 100000 100000 A 2019-12-20 2020-09-20 Common Stock 93458 100000 D On June 1, 2020, AzurRx Biopharma, Inc. (the "Company") and Edward Borkowski amended the Senior Convertible Promissory Note (the "Note") previously issued on December 20, 2019 to increase the conversion price from $0.97 per share to $1.07 per share. Represents the number of shares of the Company's common stock, par value $0.001 per share ("Common Stock") issuable upon conversion of the principal amount of the Note at the original conversion price of $0.97 per share. Represents the number of shares of Common Stock issuable upon conversion of the principal amount of the Note at the amended conversion price of $1.07 per share. /s/ Ed Borkowski 2020-06-01